Skip to main content
Top
Published in: Endocrine 3/2014

01-08-2014 | Original Article

Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone

Authors: R. Collomp, Z. Labsy, H. Zorgati, F. Prieur, F. Cottin, M. C. Do, O. Gagey, F. Lasne, K. Collomp

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

Significant alteration in hypothalamic–pituitary–adrenal function has been demonstrated in patients after short-term glucocorticoid therapy, but its impact on the circadian rhythm of steroid hormones has never been investigated. This study examined the effects of short-term prednisone administration on the diurnal patterns of dehydroepiandrosterone (DHEA) and testosterone. Saliva samples were collected from 11 healthy, physically active, male volunteers for DHEA and testosterone analysis, as follows: every 4 h from 0800 to 2000 h on 2 control days without medication, and after 1 week of oral therapeutic prednisone treatment (60 mg daily) (days 0–3). Overall, a diurnal decline in the two steroid hormones was observed on the control days. After short-term glucocorticoid administration, DHEA concentrations were significantly decreased with a complete disappearance of the DHEA diurnal pattern, which lasted 2 days post-treatment. No glucocorticoid effect was observed for testosterone. The results indicate that short-term prednisone treatment affects the circadian pattern of saliva DHEA but not testosterone in healthy active volunteers. Further studies are necessary to determine whether this alteration in DHEA circadian pattern has clinical consequences in patients with chronic glucocorticoid therapy.
Literature
1.
go back to reference F. Hucklebridge, T. Hussain, P. Evans, A. Clow, The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 30, 51–57 (2005)PubMedCrossRef F. Hucklebridge, T. Hussain, P. Evans, A. Clow, The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 30, 51–57 (2005)PubMedCrossRef
2.
go back to reference A. Oskis, A. Clow, L. Thorn, C. Loveday, F. Hucklebridge, Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescents. Stress 15, 110–114 (2012)PubMedCrossRef A. Oskis, A. Clow, L. Thorn, C. Loveday, F. Hucklebridge, Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescents. Stress 15, 110–114 (2012)PubMedCrossRef
3.
go back to reference W.J. Kraemer, C.C. Loebel, J.S. Volek, N.A. Ratamess, R.U. Newton, R.B. Wickham, L.A. Gotshalk, N.D. Duncan, S.A. Mazzetti, A.L. Gómez, M.R. Rubin, B.C. Nindl, K. Häkkinen, The effect of heavy resistance exercise on the circadian rhythm of salivary testosterone in men. Eur. J. Appl. Physiol. 84, 13–18 (2001)PubMedCrossRef W.J. Kraemer, C.C. Loebel, J.S. Volek, N.A. Ratamess, R.U. Newton, R.B. Wickham, L.A. Gotshalk, N.D. Duncan, S.A. Mazzetti, A.L. Gómez, M.R. Rubin, B.C. Nindl, K. Häkkinen, The effect of heavy resistance exercise on the circadian rhythm of salivary testosterone in men. Eur. J. Appl. Physiol. 84, 13–18 (2001)PubMedCrossRef
4.
go back to reference Z. Labsy, F. Prieur, B. Le Panse, M.C. Do, O. Gagey, F. Lasne, K. Collomp, The diurnal patterns of cortisol and dehydroepiandrosterone in relation to intense aerobic exercise in recreationally trained soccer players. Stress 16, 261–265 (2013)PubMedCrossRef Z. Labsy, F. Prieur, B. Le Panse, M.C. Do, O. Gagey, F. Lasne, K. Collomp, The diurnal patterns of cortisol and dehydroepiandrosterone in relation to intense aerobic exercise in recreationally trained soccer players. Stress 16, 261–265 (2013)PubMedCrossRef
5.
go back to reference D.A. Granger, F.B. Schwartz, A. Booth, M. Curran, D. Zakaria, Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults. Psychoneuroendocrinology 24, 567–579 (1999)PubMedCrossRef D.A. Granger, F.B. Schwartz, A. Booth, M. Curran, D. Zakaria, Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults. Psychoneuroendocrinology 24, 567–579 (1999)PubMedCrossRef
6.
go back to reference G. Lac, A. Robert, Salivary assays in saliva: a method to detect plasmatic contaminations. Arch. Int. Physiol. Biochim. Biophys. 101, 257–262 (1993)PubMedCrossRef G. Lac, A. Robert, Salivary assays in saliva: a method to detect plasmatic contaminations. Arch. Int. Physiol. Biochim. Biophys. 101, 257–262 (1993)PubMedCrossRef
7.
go back to reference R. Thomasson, A. Baillot, L. Jollin, A.M. Lecoq, V. Amiot, F. Lasne, K. Collomp, Correlation between plasma and saliva adrenocortical hormones in response to submaximal exercise. J. Physiol. Sci. 60, 435–439 (2010)PubMedCrossRef R. Thomasson, A. Baillot, L. Jollin, A.M. Lecoq, V. Amiot, F. Lasne, K. Collomp, Correlation between plasma and saliva adrenocortical hormones in response to submaximal exercise. J. Physiol. Sci. 60, 435–439 (2010)PubMedCrossRef
8.
go back to reference A. Baillot, N. Vibarel-Rebot, R. Thomasson, L. Jollin, V. Amiot, P. Emy, K. Collomp, Serum and saliva adrenocortical hormones in obese diabetic men during submaximal exercise. Horm. Metab. Res. 43, 148–150 (2011)PubMedCrossRef A. Baillot, N. Vibarel-Rebot, R. Thomasson, L. Jollin, V. Amiot, P. Emy, K. Collomp, Serum and saliva adrenocortical hormones in obese diabetic men during submaximal exercise. Horm. Metab. Res. 43, 148–150 (2011)PubMedCrossRef
9.
go back to reference M.J. Carella, L.S. Srivastava, V.V. Gossain, D.R. Rovner, Hypothalamic-pituitaryadrenal function 1 week after a short burst of steroid therapy. J. Clin. Endocrinol. Metab. 76, 1188–1191 (1993)PubMed M.J. Carella, L.S. Srivastava, V.V. Gossain, D.R. Rovner, Hypothalamic-pituitaryadrenal function 1 week after a short burst of steroid therapy. J. Clin. Endocrinol. Metab. 76, 1188–1191 (1993)PubMed
10.
go back to reference R.J. Spiegel, R.A. Vigersky, A.I. Oliff, C.K. Echelberger, J. Bruton, D.G. Poplack, Adrenal suppression after short-term corticosteroid therapy. Lancet 24, 630–633 (1979)CrossRef R.J. Spiegel, R.A. Vigersky, A.I. Oliff, C.K. Echelberger, J. Bruton, D.G. Poplack, Adrenal suppression after short-term corticosteroid therapy. Lancet 24, 630–633 (1979)CrossRef
11.
go back to reference T.B. Casale, H.S. Nelson, W.E. Stricker, H. Raff, K.B. Newman, Suppression of hypothalamic–pituitary–adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann. Allergy Asthma Immunol. 87, 379–385 (2001)PubMedCrossRef T.B. Casale, H.S. Nelson, W.E. Stricker, H. Raff, K.B. Newman, Suppression of hypothalamic–pituitary–adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann. Allergy Asthma Immunol. 87, 379–385 (2001)PubMedCrossRef
12.
go back to reference J.A. Zora, D. Zimmerman, T.L. Carey, E.J. O’Connell, J.W. Yunginger, Hypothalamic–pituitary–adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J. Allergy. Clin. Immunol. 77, 9–13 (1986)PubMedCrossRef J.A. Zora, D. Zimmerman, T.L. Carey, E.J. O’Connell, J.W. Yunginger, Hypothalamic–pituitary–adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J. Allergy. Clin. Immunol. 77, 9–13 (1986)PubMedCrossRef
13.
go back to reference A.C. Watson, R.L. Rosenfield, V.S. Fang, Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin. Endocrinol. 28, 471–475 (1988)CrossRef A.C. Watson, R.L. Rosenfield, V.S. Fang, Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin. Endocrinol. 28, 471–475 (1988)CrossRef
14.
go back to reference D. Brigell, V. Fang, R.L. Rosenfeld, Recovery of responses to ovine corticotrophin releasing hormone after withdrawal of a short course of glucocorticoid. J. Clin. Endocrinol. Metab. 74, 1036–1039 (1992)PubMed D. Brigell, V. Fang, R.L. Rosenfeld, Recovery of responses to ovine corticotrophin releasing hormone after withdrawal of a short course of glucocorticoid. J. Clin. Endocrinol. Metab. 74, 1036–1039 (1992)PubMed
15.
go back to reference L. Jollin, R. Thomasson, B. Le Panse, A. Baillot, N. Vibarel-Rebot, A.M. Lecoq, V. Amiot, J. De Ceaurriz, K. Collomp, Saliva DHEA and cortisol responses following short-term corticosteroid intake. Eur. J. Clin. Investig. 40, 183–186 (2010)CrossRef L. Jollin, R. Thomasson, B. Le Panse, A. Baillot, N. Vibarel-Rebot, A.M. Lecoq, V. Amiot, J. De Ceaurriz, K. Collomp, Saliva DHEA and cortisol responses following short-term corticosteroid intake. Eur. J. Clin. Investig. 40, 183–186 (2010)CrossRef
16.
go back to reference K. Collomp, A. Arlettaz, H. Portier, A.M. Lecoq, B. Le Panse, N. Rieth, J. De Ceaurriz, Short-term glucocorticoid intake combined with intense training on performance and hormonal responses. Br. J. Sports Med. 42, 983–988 (2008)PubMedCrossRef K. Collomp, A. Arlettaz, H. Portier, A.M. Lecoq, B. Le Panse, N. Rieth, J. De Ceaurriz, Short-term glucocorticoid intake combined with intense training on performance and hormonal responses. Br. J. Sports Med. 42, 983–988 (2008)PubMedCrossRef
17.
go back to reference P. Marquet, G. Lac, A. Chassain, G. Habrioux, F. Galen, Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones. J. Appl. Physiol. 87, 183–188 (1999)PubMed P. Marquet, G. Lac, A. Chassain, G. Habrioux, F. Galen, Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones. J. Appl. Physiol. 87, 183–188 (1999)PubMed
18.
go back to reference L. Parker, Control of adrenal androgen secretion. Endocrinol. Metab. Clin. North Am. 20, 401–421 (1991)PubMed L. Parker, Control of adrenal androgen secretion. Endocrinol. Metab. Clin. North Am. 20, 401–421 (1991)PubMed
19.
go back to reference W. Arlt, H. Justl, F. Callies, M. Reincke, D. Hubler, M. Oettel, M. Ernst, H.M. Schulte, B. Allolio, Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metab. 83, 1928–1934 (1998)PubMedCrossRef W. Arlt, H. Justl, F. Callies, M. Reincke, D. Hubler, M. Oettel, M. Ernst, H.M. Schulte, B. Allolio, Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metab. 83, 1928–1934 (1998)PubMedCrossRef
20.
go back to reference F. Labrie, A. Bélanger, P. Bélanger, R. Bérubé, C. Martel, L. Cusan, J. Gomez, B. Candas, V. Chaussade, I. Castile, C. Deloche, J. Leclaire, Metabolism of DHEA in postmenopausal women following percutaneous administration. J. Steroid Biochem. Mol. Biol. 103, 178–188 (2007)PubMedCrossRef F. Labrie, A. Bélanger, P. Bélanger, R. Bérubé, C. Martel, L. Cusan, J. Gomez, B. Candas, V. Chaussade, I. Castile, C. Deloche, J. Leclaire, Metabolism of DHEA in postmenopausal women following percutaneous administration. J. Steroid Biochem. Mol. Biol. 103, 178–188 (2007)PubMedCrossRef
21.
go back to reference P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, R.F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327–348 (1999)PubMedCrossRef P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, R.F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327–348 (1999)PubMedCrossRef
22.
go back to reference A.M. Traish, H.P. Kang, F. Saad, A.T. Guay, Dehydroepiandrosterone (DHEA)—a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960–2982 (2011)PubMedCrossRef A.M. Traish, H.P. Kang, F. Saad, A.T. Guay, Dehydroepiandrosterone (DHEA)—a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960–2982 (2011)PubMedCrossRef
23.
go back to reference E. Barrett-Connor, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 117, 807–811 (1992)PubMedCrossRef E. Barrett-Connor, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 117, 807–811 (1992)PubMedCrossRef
24.
go back to reference M.C. Jimenez, Q. Sun, M. Schürks, S. Chiuve, F.B. Hu, J.E. Manson, K.M. Rexrode, Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44, 1784–1789 (2013)PubMedCrossRef M.C. Jimenez, Q. Sun, M. Schürks, S. Chiuve, F.B. Hu, J.E. Manson, K.M. Rexrode, Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44, 1784–1789 (2013)PubMedCrossRef
Metadata
Title
Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone
Authors
R. Collomp
Z. Labsy
H. Zorgati
F. Prieur
F. Cottin
M. C. Do
O. Gagey
F. Lasne
K. Collomp
Publication date
01-08-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0122-9

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.